
RenovoRx, Inc.
RNXTNasdaqCIK 1574094HealthcareFiscal year ends Dec 31
Reports and events: 91 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-12-1816:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-23-045272 |
| 2023-11-2713:23 ET | DEF 14A | Proxy statementPeriod 2023-11-27 | 0001493152-23-042751 |
| 2023-11-1408:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-040786 |
| 2023-11-1316:58 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-040598 |
| 2023-11-0616:15 ET | 8-K | 8.01 Other events | 0001493152-23-039525 |
| 2023-09-1119:41 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-032160 |
| 2023-08-2516:15 ET | 8-K | 3.01 Delisting notice | 0001493152-23-030228 |
| 2023-08-1708:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-029240 |
| 2023-08-1614:11 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-029125 |
| 2023-06-2909:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-022862 |
| 2023-06-0916:05 ET | 8-K | 5.07 Shareholder vote results | 0001493152-23-020719 |
| 2023-05-1508:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-016947 |
| 2023-05-1216:18 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-016648 |
| 2023-05-0109:00 ET | DEF 14A | Proxy statementPeriod 2023-05-01 | 0001493152-23-014872 |
| 2023-04-2708:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-013781 |
| 2023-04-0316:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-010652 |
| 2023-03-3116:31 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-010332 |
| 2023-03-0208:30 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-006504 |
| 2023-01-1816:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-001787 |
| 2022-11-1408:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-031670 |
| 2022-11-1406:04 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-031491 |
| 2022-11-1017:24 ET | S-1 | Registration statement | 0001493152-22-031437 |
| 2022-09-1908:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-026179 |
| 2022-08-1508:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-022608 |
| 2022-08-1216:31 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-022384 |
| 2022-07-1908:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-019760 |
| 2022-06-0917:09 ET | 8-K | 5.07 Shareholder vote results | 0001493152-22-016328 |
| 2022-05-1607:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-013513 |
| 2022-05-1315:24 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001493152-22-013294 |
| 2022-04-2916:06 ET | DEF 14A | Proxy statementPeriod 2022-04-29 | 0001493152-22-011553 |
| 2022-03-3008:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-008099 |
| 2022-03-3007:21 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001493152-22-008080 |
| 2021-12-1016:15 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-21-031126 |
| 2021-11-1516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-21-028597 |
| 2021-11-1516:07 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001493152-21-028585 |
| 2021-08-3117:14 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-21-021705 |
| 2021-08-2508:58 ET | S-1/A | Registration statement, amended | 0001493152-21-021177 |
| 2021-08-1917:28 ET | S-1/A | Registration statement, amended | 0001493152-21-020730 |
| 2021-08-1218:00 ET | S-1/A | Registration statement, amended | 0001493152-21-019398 |
| 2021-08-0517:29 ET | S-1/A | Registration statement, amended | 0001493152-21-018772 |
| 2021-07-2117:15 ET | S-1 | Registration statement | 0001493152-21-017463 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:30 ET. Listed shows no prices and gives no investment advice.